The PrimeVigilance team is looking forward to exhibiting at The World Drug Safety Congress Europe in Amsterdam 27 - 29 September.
The World Drug Safety Congress Europe empowers patients, physicians, pharma, biotech, and consumers to make the best drug safety decisions. This year it will bring together 600+ key thought leaders to explore new challenges within pharmacovigilance, like the use of big data and AI in pharmacovigilance, benefit-risk management strategies examination, and patient-centric approaches. They will also discuss how to tackle the challenges of social media and drug safety legislation globally.
Our PrimeVigilance team will be exhibiting for three days in Amsterdam for the most comprehensive program and inclusive gathering of pharmacovigilance stakeholders.
If attending, we encourage you to listen to PrimeVigilance Director of Medical Writing, Dr. Vjera Bilušić Vundać, invited as a speaker on the topic “Risk Management Plan” scheduled for Sep 27 at 17:10.
Dr. Vjera Bilušić Vundać
Director of Medical Writing, PrimeVigilance
We also invite you to visit our booth #53 to meet our experts and commercial team.
Head of Global Project Management, PrimeVigilance
Alessandro Di Ranno
Vice President, Business Development Europe
Business Development Manager, PrimeVigilance
For more information about this event, please visit https://www.terrapinn.com/conference/world-drug-safety-congress-europe/index.stm
If you have any questions or want to set up a meeting with the PrimeVigilance team during the The World Drug Safety Congress Europe, you can email us at email@example.com.